- Filed
- Apr 3, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 14, 2025 | 58.48M sh |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $9.84K |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $69.42K |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $5.07M |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $4.31M |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $5.21M |
| Total Liabilities | Q3 2025 · Apr 30, 2024 | $4.46M |
| Current Assets | Q3 2025 · Jan 31, 2025 | $225.21K |
| Current Assets | Q3 2025 · Apr 30, 2024 | $564.5K |
| Total Assets | Q3 2025 · Jan 31, 2025 | $567.18K |
| Total Assets | Q3 2025 · Apr 30, 2024 | $910K |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 44.22M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 42.53M sh |
| Capex | Q3 2025 · Jan 31, 2024 | $59.5K |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | −$1M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | −$5.74M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | −$5.16M |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | −$4.99M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | −$3.86M |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | −$0.02 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | −$0.07 |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $453.01K |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $1.11M |
| Net Income | Q3 2025 · Jan 31, 2024 | −$883.64K |
| Net Income | Q3 2025 · Jan 31, 2024 | −$3.08M |
| Net Income | Q3 2025 · Oct 31, 2023 | −$975.07K |
| Net Income | Q3 2025 · Jul 31, 2023 | −$1.22M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$747.24K |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$2.43M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $161.17K |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $585.64K |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $928.41K |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $2.69M |
| Revenue | Q3 2025 · Jan 31, 2024 | $1.09M |
| Revenue | Q3 2025 · Jan 31, 2024 | $3.28M |